NDAINHALATIONSOLUTION
Approved
May 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Data completeness
4/8 — Partial
PERFOROMIST (formoterol fumarate dihydrate) by Viatris (2) is long-acting, beta 2 -adrenergic receptor agonist (beta 2 -agonist). First approved in 2007.
Drug data last refreshed Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Perforomist (formoterol fumarate dihydrate) is a long-acting beta-2 adrenergic receptor agonist (LABA) delivered via inhalation solution for maintenance treatment of asthma and COPD. It works by stimulating beta-2 receptors in bronchial smooth muscle to produce sustained bronchodilation and inhibit mast cell mediator release. The drug is indicated for asthma, COPD, and has an indication for lung cancer, though the relevance of its mechanism to oncology is unclear.
$0.732MPart D
LOE ApproachingAs an LOE-approaching product with modest Part D spending ($732K in 2023), brand teams face declining commercial momentum and may shift focus to lifecycle extensions or transition to post-LOE support roles.
Mechanism of Action
long-acting, beta 2 -adrenergic receptor agonist (beta 2 -agonist). Inhaled formoterol fumarate acts locally in the lung as a bronchodilator. In vitro studies have shown that formoterol has more than 200-fold greater agonist activity at beta 2 -receptors than at beta 1 -receptors. Although beta 2…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on PERFOROMIST at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.